About nanoappsmedical

NanoApps Medical - Official website

Cancer Drug Launched in Space – Nanotech Treatment Tested for Occurrence of Change in Zero Gravity Conditions

Drug cancer cell treatment, Doxil, manufactured by Ayana Pharma, was launched a week ago, to the International Space Station, as part of the mission of SpaceX. The launch of the drug was made possible by SpacePharma, an Israeli start-up laboratory. Since space exploration has grown because of aerospace big players such as SpaceX, the [...]

By |2022-01-04T10:02:13+00:00January 4th, 2022|Categories: News|0 Comments

Medical Technologies to Watch In 2022

The field of medicine is perhaps the area where emerging technologies are of the utmost importance. In the last decades, the development of technology has greatly benefited the medical industry. Some of the advancements include newly-emerged and more efficient and accurate equipment and new tech, as well as the integration of automated and digital services, such [...]

By |2022-01-03T15:09:14+00:00January 3rd, 2022|Categories: News|0 Comments

Biosynthesized Silver Nanoparticles Produce Successful Nanosensor

Extremely selective silver nanoparticles (AgNPs) were biochemically synthesized from Nilgirianthus Ciliatus leaves (NCL) harvest for spectrophotometric determination of Zn (II) ions to create nano detectors, according to an article published recently in Materials Research Bulletin. Under atmospheric circumstances, AgNPs were synthesized utilizing NCL extracts found in bioactive compounds. Biosynthesis of Silver Nanoparticles Metal nanoparticles of Au, Ag, [...]

By |2021-12-31T11:36:46+00:00December 31st, 2021|Categories: News|0 Comments

Protected: Lana Gilbertson

This content is password-protected. To view it, please enter the password below. Password:

By |2021-12-30T01:56:53+00:00December 30th, 2021|Categories: Book PDFs|Enter your password to view comments.

Protected: Dr. Robert Petrella

This content is password-protected. To view it, please enter the password below. Password:

By |2021-12-30T01:56:41+00:00December 30th, 2021|Categories: Book PDFs|Enter your password to view comments.

Protected: Dr. Kannan Mavila

This content is password-protected. To view it, please enter the password below. Password:

By |2021-12-29T16:39:48+00:00December 29th, 2021|Categories: Book PDFs|Enter your password to view comments.

Rethinking how drugs are administered: A breakthrough in microneedle patches

The painful feeling of receiving an injection through a hypodermic needle or with the unpleasant sensation of swallowing a large pill is a globally familiar sensation. But what if a revolutionary and gentler way of administering drugs was in the works? For over two decades, researchers have been investigating various types of microneedles as [...]

By |2021-12-28T11:11:20+00:00December 28th, 2021|Categories: News|0 Comments

US Army’s Vaccine Could Protect Against All Coronavirus Variants

Within weeks, scientists at the Walter Reed Army Institute of Research expect to announce that they have developed a vaccine that is effective against COVID-19 and all its variants, even Omicron, as well as previous SARS-origin viruses that have killed millions of people worldwide. The achievement is the result of almost two years of [...]

By |2021-12-26T13:38:52+00:00December 26th, 2021|Categories: News|0 Comments

How MXene Nanomaterials Are Unlocking Future Nanotechnologies

Two-dimensional (2D) nanomaterials like graphene have received great research attention for several years, but a new generation of atom-thick materials – MXenes – has recently captured the interest of materials science researchers and nanotechnology developers alike. Synthesizing MXene Nanomaterials MXenes are 2D nanomaterials that exhibit high conductivity, high surface area, high functionalization, a site [...]

By |2021-12-25T12:09:00+00:00December 25th, 2021|Categories: News|0 Comments

Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)

The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults amid a winter surge of cases driven by the highly infectious Omicron variant. The decision to grant an emergency use authorization came a day after the agency gave a green light to a similar but more effective [...]

By |2021-12-25T03:36:57+00:00December 25th, 2021|Categories: News|0 Comments
Go to Top